These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 12968979)

  • 1. Evaluation of new therapies for inflammatory bowel disease.
    Carty E; Rampton DS
    Br J Clin Pharmacol; 2003 Oct; 56(4):351-61. PubMed ID: 12968979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biologic therapy for inflammatory bowel disease.
    Ardizzone S; Bianchi Porro G
    Drugs; 2005; 65(16):2253-86. PubMed ID: 16266194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel strategies for the treatment of inflammatory bowel disease: Selective inhibition of cytokines and adhesion molecules.
    Nakamura K; Honda K; Mizutani T; Akiho H; Harada N
    World J Gastroenterol; 2006 Aug; 12(29):4628-35. PubMed ID: 16937430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current medical therapy for chronic inflammatory bowel diseases.
    Tamboli CP
    Surg Clin North Am; 2007 Jun; 87(3):697-725. PubMed ID: 17560421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Balancing the risks and benefits of biologic therapy in inflammatory bowel diseases.
    Trivedi I; Hanauer SB
    Expert Opin Drug Saf; 2015; 14(12):1915-34. PubMed ID: 26559664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid fecal calprotectin level assessment and the SIBDQ score can accurately detect active mucosal inflammation in IBD patients in clinical remission: a prospective study.
    Voiosu T; Benguş A; Dinu R; Voiosu AM; Bălănescu P; Băicuş C; Diculescu M; Voiosu R; Mateescu B
    J Gastrointestin Liver Dis; 2014 Sep; 23(3):273-8. PubMed ID: 25267955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabidiol in inflammatory bowel diseases: a brief overview.
    Esposito G; Filippis DD; Cirillo C; Iuvone T; Capoccia E; Scuderi C; Steardo A; Cuomo R; Steardo L
    Phytother Res; 2013 May; 27(5):633-6. PubMed ID: 22815234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New developments in the treatment of inflammatory bowel disease.
    Mutlu EA; Farhadi A; Keshavarzian A
    Expert Opin Investig Drugs; 2002 Mar; 11(3):365-85. PubMed ID: 11866666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mouse models of inflammatory bowel disease for investigating mucosal immunity in the intestine.
    Bamias G; Arseneau KO; Cominelli F
    Curr Opin Gastroenterol; 2017 Nov; 33(6):411-416. PubMed ID: 28901966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug development in IBD: from novel target identification to early clinical trials.
    Danese S; Fiocchi C; Panés J
    Gut; 2016 Aug; 65(8):1233-9. PubMed ID: 27196598
    [No Abstract]   [Full Text] [Related]  

  • 11. General principles of medical therapy of inflammatory bowel disease.
    Friedman S
    Gastroenterol Clin North Am; 2004 Jun; 33(2):191-208, viii. PubMed ID: 15177534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Moving towards disease modification in inflammatory bowel disease therapy.
    Allen PB; Peyrin-Biroulet L
    Curr Opin Gastroenterol; 2013 Jul; 29(4):397-404. PubMed ID: 23695427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inflammatory bowel diseases (IBD) -- critical discussion of etiology, pathogenesis, diagnostics, and therapy].
    Ochsenkühn T; Sackmann M; Göke B
    Radiologe; 2003 Jan; 43(1):1-8. PubMed ID: 12552369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. News from the "5th International Meeting on Inflammatory Bowel Diseases" CAPRI 2010.
    Latella G; Fiocchi C; Caprili R
    J Crohns Colitis; 2010 Dec; 4(6):690-702. PubMed ID: 21122584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotherapy in inflammatory bowel disease.
    Ahluwalia JP
    Med Clin North Am; 2012 May; 96(3):525-44, x. PubMed ID: 22703854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment Targets in Inflammatory Bowel Disease: Current Status in Daily Practice.
    Römkens TE; Gijsbers K; Kievit W; Hoentjen F; Drenth JP
    J Gastrointestin Liver Dis; 2016 Dec; 25(4):465-471. PubMed ID: 27981302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-integrin therapy for inflammatory bowel disease.
    Park SC; Jeen YT
    World J Gastroenterol; 2018 May; 24(17):1868-1880. PubMed ID: 29740202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring of therapy for inflammatory bowel disease.
    Burri E; Beglinger C; Lehmann FS
    Digestion; 2012; 86 Suppl 1():1-5. PubMed ID: 23051719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current therapy of inflammatory bowel disease in children.
    Rufo PA; Bousvaros A
    Paediatr Drugs; 2006; 8(5):279-302. PubMed ID: 17037946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of placebo therapy in inflammatory bowel disease.
    Su C
    Inflamm Bowel Dis; 2006 Apr; 12(4):328-33. PubMed ID: 16633054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.